Stocktoria
Vor Biopharma Inc. VOR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-05
Vor Biopharma Inc. statistics & valuation
Market cap$764.6M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -150.0% | -81.8% | -59.5% | -30.8% | -28.4% |
| Return on equity | 423.6% | 120.9% | -78.2% | -36.7% | -31.9% |
| Current ratio | 18.20 | 5.19 | 9.04 | 18.06 | 21.12 |
Source: SEC EDGAR filings · CIK 0001817229 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.